BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥4 | ¥4 | ¥10 | ¥5 |
| - Cash | ¥1 | ¥1 | ¥2 | ¥2 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥3 | ¥3 | ¥9 | ¥3 |
| Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| % Growth | 1,473.6% | -98.6% | -65.7% | – |
| Gross Profit | ¥0 | -¥0 | ¥0 | ¥0 |
| % Margin | 97.2% | -473.6% | 64.1% | 78.5% |
| EBITDA | -¥1 | -¥1 | -¥1 | -¥1 |
| % Margin | -101,434.2% | -1,619,147.2% | -27,783.2% | -9,386.6% |
| Net Income | -¥1 | -¥1 | -¥1 | -¥1 |
| % Margin | -101,601.9% | -1,622,336.1% | -28,137% | -9,632.6% |
| EPS Diluted | -14.12 | -18.21 | -24.9 | -28.55 |
| % Growth | 22.5% | 26.9% | 12.8% | – |
| Operating Cash Flow | -¥1 | -¥1 | -¥1 | -¥2 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥1 | -¥1 | -¥1 | -¥2 |